explore -WSS

explore

author：knowledge 2025-10-01 11:20:11 - browse：25

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Elisabeth Bik tackles the widespread issue of research misconduct

WSS

CDC advisory group OKs chikungunya vaccine

Cholera vaccine supplies dangerously low, outbreaks surging

Using force crossed my mind when examining a defiant young patient

Global childhood vaccinations edge closer to pre

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Who gets to use the title 'doctor'?

focus

explore

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Tori Bowie and the unacceptable rates of Black maternal death

Childhood vaccination ad campaign launches in the U.K.

Medical leaders decry Supreme Court decision on affirmative action

Congress likely to miss an opportunity to fix drug shortages issue

Anesthesiologist group: stop taking Ozempic before surgery

Involuntary treatment for addiction doesn't work

Activists slam private health insurers over coverage restrictions

Can CDC director Mandy Cohen drive consensus in Washington?

leisure time

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Medicare Advantage isn’t working — for anyone

Europe sees delivery challenges ahead on Alzheimer's therapies

Medicare isn't yet testing food as medicine

Does aspartame cause cancer? What new WHO guidance says

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

hotspot

focus

leisure time

Wikipedia